Atlas Trials

Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer

Clinical trial NCT04293419 · UNKNOWN

Trial details

NCT number
NCT04293419
Sponsor
Grupo Espanol Multidisciplinario del Cancer Digestivo
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2019-12-18
Primary completion
2024-12-18
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.